Stockreport

Aldeyra sets sights on U.S. application for reproxalap in dry eye disease [Seeking Alpha]

Aldeyra Therapeutics, Inc.  (ALDX) 
Last aldeyra therapeutics, inc. earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aldeyra.com/investor-relations
PDF Based on FDA feedback, Aldeyra Therapeutics (NASDAQ:ALDXlaunch two Phase 3 clinical trialsTopline results from the first Phase 3 should be available by year-end. A safet [Read more]